Posted by Michael Wonder on 16 Mar 2017
Nine submissions done and two due by month end…
16 March 2017 - Industry advocacy at AusBiotech is in ‘top gear’ with nine submissions completed on behalf of members in the past 12 weeks and two due by the end of the month.
AusBiotech’s appearance today at the Senate Inquiry hearing into the ‘Price regulation associated with the Prostheses List Framework’ joins numerous submissions made over the past few months, on issues ranging from regulation of medical technologies to intellectual property provisions for pharmaceuticals and gene technology.
AusBiotech is currently inviting members’ comments on the TGA’s consultation paper regarding changes to accessing unapproved therapeutic goods and the Senate Inquiry into funding for research for cancers with low survival rates.
